Australia is unleashing gene-editing technology like CRISPR across agriculture, medicine, and biology, revolutionising everything, from horses to humans.
Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...
MyPEAK-1 is designed to test TN-201 as a one-time gene replacement therapy for a type of heart disease called MYBPC3-associated hypertrophic cardiomyopathy. Citing data from three patients in the ...
Gene Park is a reporter for The Washington Post, covering video games and gaming culture. He joined The Post in 2015 as audience editor, and is a former reporter in the West Coast and Pacific region.